Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Rifampin on the Pharmacokinetics of Ixabepilone in Patients With Advanced Cancer

NCT00207090 is registered in ClinicalTrials.gov with R-Pharm as lead sponsor.

NCT NCT00207090
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00207090 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Rifampin on the Pharmacokinetics of Ixabepilone in Patients With Advanced Cancer
Lead sponsor
R-Pharm
Phase
Phase 1
Overall status
Completed
Start date
September 30, 2005
Completion date
November 30, 2008
Enrollment
19 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid tumors, neoplasms